Vidal-Oliver, Lourdes
Herzig-de Almeida, Elisa
Spissinger, Sabrina
Dolz-Marco, Rosa
Finger, Robert P.
Funding for this research was provided by:
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 5 September 2024
Accepted: 19 November 2024
First Online: 22 November 2024
Declarations
:
: L Vidal-Oliver: Bayer (travel expenses); E Herzig-de Almeida, None; S Spissinger, None; R Dolz-Marco: Heidelberg Engineering (consultant), Roche, Abbvie (financial support); RP Finger: Biogen, Bayer (sponsoring or research money), Apellis, Allimera, Allergan, Astellas, Caterna, Böringer-Ingelheim, Novartis, Ophthea, ODOS, ProGenerika, Roche/Genentech, Stada Pharm (Honorary or other (financial) compensation).